Epidermolysis bullosa acquisita: A comprehensive review

Keyphrases

• Bullae 100%
• Autoantibodies 100%
• Epidermolysis Bullosa Acquisita 100%
• Collagen VII 100%
• Trauma 50%
• Clinical Practice Guidelines 50%
• Randomized Controlled Trial 50%
• Neutrophil Activation 50%
• Diagnosis Treatment 50%
• Noninflammatory 50%
• Clinical Presentation 50%
• In Vivo murine Model 50%
• Novel Therapeutic Targets 50%
• Blister 50%
• Bullous Pemphigoid 50%
• Mucous Membrane 50%
• Confirmatory Test 50%
• Autoimmune Blistering Diseases 50%
• Mucous Membrane Pemphigoid 50%
• Inflammatory Lesions 50%
• Linear IgA Bullous Disease 50%
• Preclinical Testing 50%
• Specialized Center 50%

Medicine and Dentistry

• Blister 100%
• Autoantibodies 100%
• Epidermolysis Bullosa Acquisita 100%
• Randomized Controlled Trial 50%
• Biological Product 50%
• Immunoglobulin A 50%
• Serositis 50%
• Bullous Pemphigoid 50%
• Immunosuppressant 50%
• Diseases 50%
• Cicatricial Pemphigoid 50%
• Bullous Disease 50%
• Leukocyte Activation 50%